AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV
Volume 20, Issue 10, 2008, Pages 1161-1168
HIV vaccine acceptability among immigrant Thai residents in Los Angeles: A mixed-method approach (Article)
Lee S.-J.* ,
Brooks R.A. ,
Newman P.A. ,
Seiden D. ,
Sangthong R. ,
Duan N.
-
a
Center for HIV Identification, Prevention, and Treatment Services, Semel Institute Center for Community Health, University of California, Los Angeles, CA, United States
-
b
Center for HIV Identification, Prevention, and Treatment Services, Semel Institute Center for Community Health, University of California, Los Angeles, CA, United States
-
c
Faculty of Social Work, Centre for Applied Social Research, University of Toronto, Toronto, ON, Canada
-
d
Semel Institute Center for Community Health, University of California, Los Angeles, CA, United States
-
e
Prince of Songkla University, Songkla, Thailand
-
f
Columbia University, New York State Psychiatric Institute, New York, NY, United States
Abstract
This study examined HIV vaccine acceptability among immigrant Thai residents in Los Angeles, California. We combined a qualitative research method (focus groups) with an innovative market research method (conjoint analysis). Focus groups explored social issues, concerns, barriers and motivators associated with HIV vaccine acceptability. Conjoint analysis was used to assess preferences among eight hypothetical HIV vaccines with varying attribute profiles and the impact of various attributes on acceptability. Five main themes were identified in the focus groups regarding acceptance and utilization of preventive HIV vaccines: (1) vaccine characteristics, such as efficacy, physical side-effects and cost, (2) fear of a vaccine, (3) vaccine acceptability and optimism, (4) social and family responses and (5) behavioral disinhibition. Conjoint analysis revealed HIV vaccine acceptability ranging from 7.4 (SD = 19.4) to 85.2 (SD = 24.3) across eight hypothetical vaccines. The vaccine with the highest acceptability had the following attributes: 99% efficacy, no side-effects, 10 years of protection, protects against one sub-type, free, one dose and given by injection. Vaccine efficacy had the greatest impact on acceptability (51.4, p=.005), followed by side-effects (11.1, p=.005) and duration of protection (8.3, p=.005). Despite some apprehensions and concerns, Thai residents perceived an HIV vaccine as making an important contribution to society and to protecting oneself and one's family from HIV infection. Nevertheless, acceptability of a partially efficacious vaccine may be low, suggesting the need for tailored social marketing interventions that might emphasize a collectivistic rather than an individualistic focus. Assessing HIV vaccine acceptability using a mixed-method approach is feasible with Thai residents and should lend itself to HIV vaccine research with other Asian Pacific Islander populations in the US. © 2008 Taylor & Francis.
Author Keywords
Index Keywords
Link
https://www.scopus.com/inward/record.uri?eid=2-s2.0-56549084538&doi=10.1080%2f09540120701855375&partnerID=40&md5=3fac40097281be32432dcaf8ee1937fe
DOI: 10.1080/09540120701855375
ISSN: 09540121
Cited by: 17
Original Language: English